Stay updated with breaking news from Dennisp Wolf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Codexis (NASDAQ:CDXS – Get Rating) in a report issued on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock. CDXS has been the subject of a number of other reports. Cowen initiated coverage on Codexis in a research report on Wednesday, March 2nd. They set a […]
Wall Street brokerages expect that Codexis, Inc. (NASDAQ:CDXS – Get Rating) will report $29.60 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Codexis’ earnings, with estimates ranging from $27.60 million to $31.70 million. Codexis reported sales of $18.03 million during the same quarter last year, which […]
Taylor Frigon Capital Management LLC trimmed its stake in Codexis, Inc. (NASDAQ:CDXS – Get Rating) by 18.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 199,868 shares of the biotechnology company’s stock after selling 45,106 shares during the quarter. Codexis accounts for about 2.0% of Taylor Frigon Capital Management LLC’s holdings, making the stock […]
Codexis, Inc. (NASDAQ:CDXS – Get Rating) shares hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $16.48 and last traded at $16.55, with a volume of 4714 shares changing hands. The stock had previously closed at $16.97. Several brokerages have recently issued reports on CDXS. TheStreet lowered […]